Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Obstetrics > Infections > Flashcards

Infections Flashcards

1
Q

CMV - IgM + - what % have infection?

A

25%

Can persist for months after primary infection, and recur with reactivation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Symptoms primary CMV

A

Usually asymptomatic

May have a viral illness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Risk factors for CMV acquisition

A

Child care workers (12% seroconversion/y)

parents with children in day are

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

CMV general population seroconversion

A

2%/y

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Prenatal diagnostic testing

A

Amnio for CMV PCR
at least 6 weeks after primary infection
Sensitivity ~100% >21/40

USS low sensitivity and specificity `

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

USS features of CMV

A 
Microcephaly 
Ascites
Oligo/poly
Abdominal/intracranial calcification
hydrocephalus
Hydrops
IUGR
Hepatomegaly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Prevention of CMV transmission

A
  1. No role of IVIG in prevention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Management of confirmed foetal CMV infection

A
  1. TOP, with the knowledge it is difficult to predict the severity of infection based on PCR and USS
  2. IVIG - better clinical outcomes for babies at 1 year in one non-randomised trial
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CMV - risk of transmission with seroconversion

  • risk of symptomatic CMV
  • risk of sequelae
A

30%

  • with transmission: (overall 10-20% risk long term squeal of congenitally infected child)
  • 10% symptomatic > 50% sequelae
  • 90% asymptomatic > 10% sequelae
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clinical signs of symptomatic CMV

A
  • high early mortality
  • microphaly
  • seizures
  • chorioretinitis
  • developmental delay
  • sensorineural hearing loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Newborn Ix for CMV

A
  • Examination
  • Serology
  • Urine/salive PCR

> if + then opthal and radiological (USS and MRI)

> Rx w oral valganciclovir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Practices for reducing infection with CMV

A
  1. Assume children <3y in your care have CMV
  2. Thoroughly wash hands with soap and water after touching child/toys/nappies/feeding/bathing etc
  3. Don’t share cups, plates, utensils, toothbrushes or food
  4. Do not kiss the child on or near the mouth
  5. Do not share a bed w the child
  6. Do not share towels or washcloths
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Prevalence rubella

A

1/100 000 pregnancies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Symptom rubella infection

A

50% asymptomatic
Vague coryzal symptoms
Examthem: maculopapular, face>trunk, resolves face>trunk
+/- polyarthralgia
+/- tender lymphadenopathy
Forchemers spots (rose like) on soft palate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Diagnosis of rubella infection

A

4x increase in IgG titre (usually 2/52)
IgM +
Culture +
Amnio/CVS PCR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Diagnosis of neonatal congenital rubella infection

A

IF IgM + at birth > retest 1/12

Infant Rubella IgG higher for longer than expected (maternal IgG lasts ~6/52)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Chance of foetal infection across gestations (Rubella)

A

T1 80%
T2 30%
T3 100%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Congenital rubella infection vs congenital rubella syndrome

A 
Infection:
- MC
- SB
- Birth defects
- Asymptomatic
- IUGR
Syndrome:
= constellation of birth defects 
- hearing impairment
- congenital heart defect
- cataracts/glaucoma
- pigmentary retinopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Rx rubella in pregnancy

A

Prevention - vaccine prepreg
Supportive care
Rx of complications e.g. steroids for thrombocytopenia
Manage the foetus: discuss TOP (esp <16/40), no direct in utero Rx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Manifestations of congenital infection EARLY

A
  • Hearing loss 60%
  • Heart defects 45% (PDA, pulmonary stenosis)
  • Microcephaly 25%
  • Cataracts 25%
  • IUGR 25%
  • hepatosplenomegaly/jaundice/purpura/pneumonitis
  • meningoencephalitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Manifestations of congenital rubella infection LATE

A
  • Hearing loss
  • Intellectual disability
  • DM
  • Thyroid dysfn
  • Progressive pan-encephalitis
  • Immune defects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Neonatal follow up after rubella infection

A
  • Clinical attendants at birth should be rubella immune
  • IX: IgM, Urine PCR, culture urine and throat swab (can take weeks)
  • Opthal, cardiac and hearing assessments at birth
  • Regular clinical assessment
  • May be infectious for 1y of life
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Risk of congenital defects by gestational age (Rubella)

A

T1 ~85%
13-16/40 ~35%
>16/40 - rare

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

HSV seroprevalence

A

HSV 1= 60%

HSV 2 = 20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Risk of HSV transmission if in genital tract in labour (recurrent)

A

HSV 1 15%
HSV 2 <0.01%
Overall 1-3%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

HSV - difference between primary and non-primary first infection?

A

Primary - HSV 1 and 2 serology negative

Non-primary = seropositive for other serotype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Risk of HSV transmission for primary HSV?

A

If maternal seroconversion well before efelivery e.g. prior to 30-24/40, then as for recurrent.
No maternal seroconversion - 25-50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Can you get in utero HSV infection?

A

Yes
Rare
<1%
Can cause abortion, PTB and IUGR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Scalp clip with known genital HSV?

A

No

Increases transmission RR 6.8!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Indications for CS with HSV?

A
  • New HSV diagnosed in labour
  • Primary HSV diagnosed late in pregnancy
  • After maternal discussion with recurrent lesions in labour
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Exposed neonate (primary or systemic infection), or neonate with symptoms (skin lesions, seizures, sepsis, low plt, deranged LFTs, DIC, resp distress, corneal ulcers)

A

Ix: LP, LFTs, FBE, HSV PCR blood, surface swabs

Immediately commence IV Aciclovir20mg/kg TDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Recurrent genital HSV lesins in labour

A

Leave membranes intact as long as possible
Avoid FBS
Avoid instrumental delivery
Expedite delivery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Listeria - organism

A 
Bacteria
Listeria monocytogenes
Aerobic, facultative anaerobe
Motile
B-haemolytic
Gram + rod
Tumbling motility by light microscopy
Grows well at refrigeration temperatures 
Predilection for the placenta and CNS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Listeria - Symptoms

A 
Febrile flu like illness
Malaise / HA / Backache
Abdo pain
Pharyngitis
Conjunctivitis
Diarrhoea
ARDS
Asymptomatic (1/3)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Ix Listeria

A

Blood culture

Genital tract gram stain and culture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Rx Listeria

A

Amoxycillin/Ampicillin 2g Q6H IV x14/7
Gent x 14/7
(Pen allergy Trimethoprim/Sulphamethoxazole - not in T1, w folate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Incidence Listeria

A

0.3/100 000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Foetal mortality w maternal Listeriosis T2/3?

A

~50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Asymptomatic individuals with consumption of food implicated in outbreak of Listeria - Rx?

A

Yes (suggested)

Amoxyl 2-3g/d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Incubation Listeria

A

Broad
1-67 days
Preg average 6/52

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Neonatal symptoms of Listeriosis

A

Granulomatosis infantiseptica - placenta, cord or post pharyngeal granulomas, small skin granulomas, pustular skin rash
MEc liquor < 34/40
Pneumonitis
Purulent conjunctivitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Neonatal Ix and Rx

A

Culture: placenta, swabs, blood cultures, urine and CSF
CXR
FBE
Rx: Amoxycillin and Gent (14-21 days dependent on culture results)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Perinatal listeriosis

A

Early onset <7/7

  • often fulminant disease
  • mort 20-60%

Late onset 7/7-6/52

  • usually meningitis or sepsis
  • mort 10-20%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Symptoms of Malaria infection

A 
Parasitaemia peaks T2
Fever (may be periodic) / Chills/ Sweats
Myalgia
Fatigue
Nausea
Janudice
Diarrhoea
Abdo pain
Cough
Pregnancy:
- MOre severe disease
- More hypoglycaemia and ARDS
- More splenomegaly
- More anaemia (may protect against placental malaria)
45
Q

Risks of Malaria to pregnancy

A 
MC
IUGR
PTB
PNM
Congenital infection
Maternal anaemia/death
46
Q

Management Malaria in pregnancy

A
  1. PRevention
  2. Hb and Plts
  3. Falciparum (80%) - Quinine and Clindamycin, or Artensunate (complicated)
  4. Vivax - Chloroquinine
47
Q

ABCD of Malaria prevention

A

Awareness of risk (highest risk papua/solomons/vanauatu/subsaharan africa)
Bite prevention (insecticide, repellant (50% deet) nets, clothes)
Chemoprophylaxis (dependent on area of travel and trimester - Mefloquine safe)
Diagnosis and treatment must be prompt

48
Q

Symptoms of severe malaria

A 
Coma
Hypoglycaemia (secondary to hyperinsulinaemia - common with Quinine)
Shock
Pulmonary oedema (ARDS)
Convulsions
renal failure
Coagulopathy
Renal failure
Metabolic acidosis
Severe anaemia
49
Q

Risk of congenital Malaria?

A

Most when infection around the time of delivery
8-33%
Send the placenta
All babies thick and thin films within first 28 days

50
Q

Hep C Incidence Oz

A

1-2%

51
Q

Hep C risk of sexual transmission

A

<5%

52
Q

Which Hep C genotypes respond best to treatment?

A

3,4,5 - 55% response
0,1,2 - 30% response

Rx w Interferon and rubaviron

53
Q

What is the risk of vertical transmission of Hep C?

A

5% overall

RNA - <1%
RNA + 11%
RNA + and HIV 16%

Active drug users at higher risk of transmission

54
Q

What are the implications of HCV RNA - ?

A
  • Low level viraemia
  • False + Ab test
  • Past cleared infection
  • Still must test the infant at 18/12
55
Q

How should you test the baby from a HCV infected mother?

A

Abs at 12/12 - most uninfected babies will be negative

If AB + check RNA and LFTs

56
Q

Can you treat HCV in pregnancy?

A

No - Rx is contraindicated

Should refer for consideration of post partum treatment

57
Q

What factors increase the risk of vertical transmission of HCV?

A
  • RNA +
  • high viral load
  • HIV co-infection
  • PROM
  • Invasive procedures
58
Q

Can women w HCV breastfeed?

A

Yes

If cracked nipples consider discarding milk while waiting for them to heal

59
Q

What is the risk of vertical transmission of HIV?

A

~45% without treatment

<2% with treatment

60
Q

PRevalence HIV

A

Geography dependent

England 0.1%

61
Q

What symtoms may occur with HIV infection?

A 
Primary:
- Fatigue
- Lymphadenopathy
- Fever
- Rash
Other:
- Persistent generalised lymphadenopathy
- Weightloss
- Fevers
- Diarrhoea
- Encehalopathy
62
Q

What are some opportunistic infections w HIV?

A
  • Pneumocyctis
  • Cerebral Toxo
  • CMV retinitis
  • TB
  • Mycobacterium avium
  • Karposi
  • NHL
  • Cryptococcus
63
Q

Outline features of pretest counselling

A
  • Confidentiality
  • Ascertain risk factors and timing of potential exposure
  • Ascertain details on previous testing
  • Outline why the test is done
  • Outline contact tracing requirements
  • Implications of results
  • Confirm results will be given in person
64
Q

Effect of pregnancy on HIV:

A
  • No major effect on progression, incl to AIDS
  • Opportunistic infections may be less aggressively investigated or treated, esp if HIV status unknown
  • Normal pregnancy associated with a reduction in cell medicated immunity - there is a decrease in number but NOT a decrease in % of CD4 cells
65
Q

Effect of HIV on pregnancy:

A
  • Increased risks: MC, PTB, IUGR (esp w advanced disease)

- No increase in congenital anomalies

66
Q

HIV - factors that increase MTCT:

A
  • High viral load
  • Serovenoversion during pregnancy
  • Advanced maternal disease
  • Poor immunological status (low CD4)
  • PROM (>4h doubles the risk)
  • Preterm labour
  • Vaginal delivery
  • Antepartum invasive procedures (CVS, Amnio, FBS)
  • Intrapartum invasive procedures (epis, FSE, instrumental)
  • Prem
  • Low BW
  • Breastfeeding and mixed breast/bottle feeding
  • Smoking
  • Choreoamnionitis
67
Q

Management of HIV in pregnancy:

A
  • Other sexual health screening
  • MDT
  • Cotrimoxazole and Folate IF CD4<200, AIDS or previous pneumocystis
  • HAART for: maternal wellbeing, or from 24/40 if from PMTC, stay on if already on. (Zidovudine and lamivudine +/- 3rd agent
68
Q

Risks in pregnancy of HAART

A

Protease inhibitors increase GDM
Increased risk PET/IUGR
Immune reconstitution inflammatory syndrome (IRIS) (paradoxical worsening of a condition on commencement of HAART esp VZV, HSV)

69
Q

Intrapartum management

A
  • CS reduces transmission, but unknown if benefit after one of labour or SROM
  • May consider VD if undetectable VL 4-6/52 prior to delivery
  • Early cord clamping and bath the baby may reduce transmission
  • Bottle feed
  • Universal precautions
70
Q

Which patients with HIV get intrapartum Zidovudine?

A
  • those w high viral load at 36 weeks (>50 copies/ml, between 50-400/ml may consider, >400 definitely)
  • Late presenters (get additional raltegravir or nevi rapine depending on VL)
71
Q

Are there foetal risks of ART?

A
  • No described adverse events
  • No HIV embryopathy described
  • Efavirenz and Didanosine are terotogenic, stavudine shouldn’t be prescribed in pregnancy
72
Q

How should be treat the baby?

A

Dependent on high vs low risk MTCT

  • low risk: Zidovudine
  • High risk: multi drug therapy, + PJP prophylaxis until HIV infection excluded

Start as soon as possible after birth
For 2-4 weeks depending on gestation at birth
Test the baby (W DNA or RNA PCR) at 6 weeks and 3 months, at least 2 weeks after prophylaxis has stopped
Only test w Ab > 18/12

73
Q

Who should we test for TB?

A

HIV +
Close contact w TB
Recent arrival from area of high prevalence
Symptomatic

74
Q

How should we test for TB?

A

Tuberculin skin test (unaffected by pregnancy)
IGRA (interferon gamma release assay)
Physical examination

75
Q

Signs of TB

A
  • Any chest sign - most commonly upper lobe crackles , can have tracheal deviation secondary to fibrosis and scarring, dullness to percussion over the clavicle
  • Lymphadenopathy
  • Erythaema nodosum
  • Extrapulmonary infection: LN, bone, liver, spleen, bone marrow, caecum, CNS, eye
76
Q

Effect of pregnancy on TB

A
  • No evidence of increased disease progression
  • Congenital TB via umbilical cord is rare
  • Neonatal TB via maternal airborne transmission is a concern in developing countries
77
Q

Management of TB in pregnancy

A

Similar to non-pregnant
MDT
Active TB in pregnancy should be treated immediately
Active dx w supervised course of more than 1 drug that the organism is sensitive to (RIPE):
Rifampicin > Vit K secondary to cytochrome induction
Isoniazid > Pyridoxine to reduce peripheral neuritis
Pyrazinamide
Ethambutol

> Monitor LFTs

Send the placenta for culture and histopath

78
Q

How should the baby of a TB + mother be treated?

A

Normally the mother is not infectious within 2 weeks of treatment
Sputum + mothers > Rx baby w Isoniazid (or drug that the organism is sensitive to ) usually for 6 months
Give the baby the BCG vaccine
Women should continue to breastfeed

79
Q

Symptoms of neonatal TB

A 
Resp distress
Poor feeding
Hepatosplenomegaly
Fever
Lymphadenopathy
80
Q

Which babies should get the BCG vaccine

A

Aboriginal babies
Born to mothers w TB
Infants of migrant parents
Those travelling to area of high incidence of TB

81
Q

Streptomycin in pregnancy?

A

No!
cat D
Known teratogen
May cause congenital deafness

82
Q

Risk factors for GBS

A
  • 18/24
  • GBS bacturia (correlation with more heavily colonised baby and high risk of EOGBS)
  • Previous GBS affected baby
  • Intrapartum fever >38 degrees
83
Q

Early onset GBS incidence

A

1/1000 all pregnancies
Untreated GBS + 1/200
70% of infants born to GBS + mothers are colonised
90% symptomatic within 12h of birth

84
Q

Culture screening versus risk factor based screening

A

RR 0.46 for prevention of EOGBS.
(This was a retrospective cohort study)
CDC, ACOG and RANZCOG support
RCOG does not support (? not cost effective)

85
Q

Anorectal collection of GBS swab - increased detection?

A

Yes
25%
Request sensitivities if penicillin allergic

86
Q

Rate maternal anaphylaxis to penicillin

A

1/100 000

Less severe reactions in 7-10%

87
Q

Penicillin hypersensitivity

A

Cephazolin 2g IV, then 1g Q8H
Anaphylaxis
Clindamycin 600mg IV Q8H (30% resistance) or Vancomycin

88
Q

Reduction in EOGBS w chemoprophylaxis

A

1.5/1000 > 0.3/1000

Late onset GBS has remained unchanged (>1/52)

89
Q

What are the infective stages of Toxoplasmosis?

A

i. Oocyte - in cat faeces, infective after 1-5 days
ii. Tachyzoite
iii. Bradyzoite - in undercooked meat/soil/fruit and veg - contained in cysts this not penetrable by ABs. Need to wait until develop into bradyzoites

90
Q

Incidence of Toxo infection in pregnancy

A

1-8/1000 (highest France)

91
Q

What are the symoptoms of maternal Toxo infection

A

May be asymptomatic

Can have fever, malaise, fatigue, headache +/- lymphadenopathy

92
Q

Toxo - risk of foetal infections

A 
increases with GA
Preconceptin 0% (unless immunocompromised)
T1 15% >likely severe outcomes
T2 45% > intermediate risk outcomes
T3 70% > usually mild infection
93
Q

What are some USS findings of Toxo

A

Hyperechoic lesions/calcifications
VM - usually symmetrical and bilateral
Changes can be rapidly progressive
NOT SB/IUGR

94
Q

Diagnosis of Toxo infection

A
  1. Serology - 2 weeks apart. IgM last 10/12. Can check IgG avidity +/- IgA.
  2. Amnio PCR > 4/52 after infection
  3. Placental histopath (cysts, deciduitis, villous sclerosis, chronic vascular thromboses, +/- free trophozoites)
95
Q

Rx Maternal Toxo

A

Controversial if any Rx reduces MTCT
Foetal infection should be treated as it reduces the serious neurological squealer and death.
NNT mat inf 18
NNT foetal inf 3

Spiramycin 1g PO TDS > doesn’t cross placenta and thus won’t treat an infected foetus
OR
Pyrimethamine and Sulphonamide (+ Folate)

96
Q

Prevention of Toxo

A 
Avoid unfiltered water
Avoid travelling S America (more severe infection)
Wash fruit and veg
Cook meat thoroughly
Avoid cat faeces
Excellent hand hygiene
97
Q

What is the classic triad of neonatal Toxo?

A

Chorioretinitis
Hydrocephalus
Intracranial calcifications

98
Q

What examinations should be performed on the newborn with clinical suspicion of toxo?

A 
Physical exam
- chorioreitinitis
- seizures-
- fever
- hepatosplenomegaly
- pneumonitis
- anaemia
- jaundice 
- lymphadenopathy
Eye exam
LP 
Cranial imaging for calcifications and hydroceph
Hearing exam
Follow up serology
99
Q

Rx neonatal toxo

A

examination and Ix

If infection, even if asymptomatic Rx w pyrimethamine for 6/12 (+ folate)

100
Q

What is the prevalence of VZV sero+?

A

95%

101
Q

What is the risk of embryopathy w VZV infection in pregnancy

A

Low

28/40 no reports

102
Q

What are the symptoms of congenital varicella?

A 
Limb hypoplasia
Skin spots
Nerological abnormalitis
Structural eye damage
MEntal retardation 50%
103
Q

What is the infectious period for varicella?

A

From 48h prior to rash up to when the lesions are crusted over

104
Q

What is defined as ‘significant exposure’ to varicella?

A

Same household
Face to face for 5 minutes
same room 1h

105
Q

How do you manage significant exposure to varicella?

A

No PHx chichenpox
Unknown or neg IgG -
- 96h consider oral acyclovir if at risk (second half of pregnancy, smoker, immunocompromised, EO complications > IV)

The patient remains infectious for up to 1/12 after ZIG

106
Q

What are defined as maternal complications of VZV?

A
  • Pregnant women more prone to complications and excess morbidity
  • New lesions ater 6 days
  • ongoing fevers after 6 days
  • haemorrhagic rash or bleeding
  • respiratory symptoms
  • neurological sympotms
107
Q

What is the role of amnio in VZV infection?

A

Generally not advised - low risk of congenital effects

- Use USS (5/52 post infection) or MRI to guide prognosis

108
Q

How accurate is a hx of chicken pox for serology?

A

97-99%

Possibly less accurate in women born or raised overseas

109
Q

How should you manage maternal VZV at term?

A 
Delay delivery 5-7 days to allow transfer of antibodies
Organise neonatal opthal exam at birth
Rx ZIG (no benefit once chicken pox occur)

Obstetrics (3 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions